SAN DIEGO, May 5, 2025 /PRNewswire/ -- Phanes Therapeutics, Inc. (Phanes), a clinical stage biotech company focused on innovative drug discovery and development in oncology, announced today that ...

Together with its asset construction division, Oryx Solar System Solutions LLC (Oryx), Phanes Group is delivering the Middle East’s largest distributed solar project. Stefanos Lialios ...

As previously announced, Phanes is conducting this study under a clinical supply agreement with Roche. Peluntamig is Phanes' first-in-class native IgG-like bispecific antibody (bsAb) targeting ...

Phanes Therapeutics, Inc. (Phanes), a clinical stage biotech company focused on innovative drug discovery and development in oncology, announced today that the first patient has been dosed in the ...